ICUI Stock Analysis: Buy, Sell, or Hold?
ICUI - ICU Medical Inc
$136.14
-4.23 (-3.01%)
▼
5d:
-4.26%
30d:
+5.28%
90d:
+8.6%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When ICUI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ICUI shows positive signals but monitor for confirmation. Market pricing in 2.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ICUI shows positive signals but monitor for confirmation. Market pricing in 2.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$226.98
Based on 9.0% avg growth
INTRINSIC VALUE TODAY
$140.94
3.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICUI is currently trading at $136.14, which is considered fair relative to its 30-day fair value range of $128.63 to $141.45. The stock's valuation (Forward PE: 14.6) is in line with its historical norms (15.9). Remarkably, the market is currently pricing in an annual earnings decline of 2.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ICUI is in a downtrend. The price is currently testing key support at $135.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $172.50 (+26.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICUI is in a downtrend. The price is currently testing key support at $135.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $172.50 (+26.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$128.63 -
$141.45
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.6%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 26.7% below Wall St target ($172.50)
Trading Range Analysis
30-Day Trading Range
$128.63 -
$141.45
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$135.53
Resistance Level
$145.25
Current Trend
Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.63
Wall Street Target
$172.50
(+26.7%)
Revenue Growth (YoY)
-12.3%
Earnings Growth (YoY)
-23.8%
Profit Margin
2.1%
Valuation Discount vs History
-2.7% cheaper
PE vs Historical
14.6 vs 15.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.7%
(market-implied from PE analysis)
1-Year Target
$132.46
(-3%)
2-Year Target
$128.89
(-5%)
3-Year Target
$125.41
(-8%)
3-Yr Target (if PE normalizes)
(PE: 15→16)
$136.25
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 14.0%)
$300.46
(+121%)
Base:
(SPY PE: 14.6, Growth: 14.0%)
$201.89
(+48%)
Bear:
(PE: 12.4, Growth: 14.0%)
$171.61
(+26%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Forward PE: 17.21 | Forward EPS (Implied): $7.91
Bull Case
$164.39
(+21%)
Analyst growth 15.0%, PE expands to 18.1
Base Case
$136.14
(0%)
Market implied 0.0%, PE stable at 17.2
Bear Case
$104.15
(-24%)
Severe decline -15.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.6 to 15.9
Stabilization Target:
$147.91
(+8.6%)
PE Expansion Potential:
+8.6%
Share & Embed Analysis
Last updated: June 23, 2026 8:04 AM ET
Data refreshes hourly during market hours. Next update: 9:04 AM
Data refreshes hourly during market hours. Next update: 9:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICUI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 55 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 62 BUY |
